Skip to main content
Top

International Journal of Hematology

Issue 3/2016

Including PIH Articles on Mechanisms of action of novel drugs in multiple myeloma and those responsible for the acquired resistance

Content (20 Articles)

Images in Hematology

Epithelioid haemangioendothelioma infiltrating bone marrow

Hui Yin Lim, Sandy Darling, Frank Hong

Progress in Hematology

Histone deacetylase inhibitors in multiple myeloma: from bench to bedside

Takeshi Harada, Teru Hideshima, Kenneth C. Anderson

Review Article

Role of Geminin in cell fate determination of hematopoietic stem cells (HSCs)

Shin’ichiro Yasunaga, Yoshinori Ohno, Naoto Shirasu, Bo Zhang, Kyoko Suzuki-Takedachi, Motoaki Ohtsubo, Yoshihiro Takihara

Rapid Communication

Transition of adult T-cell leukemia/lymphoma clones during clinical progression

Sakura Aoki, Sanaz Firouzi, Yosvany López, Tadanori Yamochi, Kazumi Nakano, Kaoru Uchimaru, Atae Utusnomiya, Masako Iwanaga, Toshiki Watanabe

Original Article

Elevated levels of miR-210 correlate with anemia in β-thalassemia/HbE patients

Panjaree Siwaponanan, Suthat Fucharoen, Pornpan Sirankapracha, Pranee Winichagoon, Tsukuru Umemura, Saovaros Svasti

Original Article

Causes of macrocytic anemia among 628 patients: mean corpuscular volumes of 114 and 130 fL as critical markers for categorization

Natsuko Takahashi, Junichi Kameoka, Naoto Takahashi, Yoshiko Tamai, Kazunori Murai, Riko Honma, Hideyoshi Noji, Hisayuki Yokoyama, Yasuo Tomiya, Yuichi Kato, Kenichi Ishizawa, Shigeki Ito, Yoji Ishida, Kenichi Sawada, Hideo Harigae

Original Article

High IL-7 levels in the bone marrow microenvironment mediate imatinib resistance and predict disease progression in chronic myeloid leukemia

Xiaoyan Zhang, Huaijun Tu, Yazhi Yang, Qian Wan, Lijun Fang, Qiong Wu, Jian Li

Original Article

Prognostic impact of RUNX1 and ETV6 gene copy number on pediatric B-cell precursor acute lymphoblastic leukemia with or without hyperdiploidy

Nuket Yurur Kutlay, Esra Pekpak, Sule Altıner, Talia Ileri, Arzu Nedime Vicdan, Handan Dinçaslan, Elif Unal Ince, Fatma Ajlan Tukun

Original Article

A retrospective study of R-CHOP/CHOP therapy-induced nausea and vomiting in non-Hodgkin’s lymphoma patients: a comparison of intravenous and oral 5-HT3 receptor antagonists

Tsutomu Takahashi, Satoshi Kumanomidou, Saki Takami, Takahiro Okada, Koji Adachi, Yumi Jo, Fumiyoshi Ikejiri, Chie Onishi, Koshi Kawakami, Takaaki Miyake, Masaya Inoue, Ichiro Moriyama, Ritsuro Suzuki, Junji Suzumiya

Original Article

The value of serum Wisteria floribunda agglutinin-positive human Mac-2-binding protein as a predictive marker for hepatitis C virus-related complications after systemic chemotherapy

Haruhito Totani, Shigeru Kusumoto, Yasuhito Tanaka, Nana Suzuki, Shinya Hagiwara, Shiori Kinoshita, Etsuko Iio, Asahi Ito, Masaki Ri, Takashi Ishida, Hirokazu Komatsu, Shinsuke Iida

Case Report

Two cases of primary adult T-cell leukemia/lymphoma of bone: case reports and a review of the literature

Takuro Kuriyama, Noriaki Kawano, Kiyoshi Yamashita, Ikuo Kikuchi

Case Report

Classical Hodgkin lymphoma primary refractory to brentuximab vedotin, with transformation to CD30-positive diffuse large B-cell lymphoma

Shinichi Makita, Akiko Miyagi Maeshima, Hirokazu Taniguchi, Hideaki Kitahara, Suguru Fukuhara, Wataru Munakata, Tatsuya Suzuki, Dai Maruyama, Yukio Kobayashi, Kensei Tobinai

Case Report

Late relapsing mantle cell lymphoma showing preserved sensitivity to single-agent lenalidomide

Adrian Tempescul, Jean-Christophe Ianotto, Cristina Bagacean, Pierre-Yves Salaun, Corina Bocsan, Mihnea Zdrenghea

Case Report

Long-term survival of donor bone marrow multipotent mesenchymal stromal cells implanted into the periosteum of patients with allogeneic graft failure

L. A. Kuzmina, N. A. Petinati, N. V. Sats, N. J. Drize, N. V. Risinskaya, A. B. Sudarikov, V. A. Vasilieva, M. Y. Drokov, E. D. Michalzova, E. N. Parovichnikova, V. G. Savchenko

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine